Rogaine 2: Clinically Proven Topical Treatment for Hair Regrowth
| Product dosage: 60ml | |||
|---|---|---|---|
| Package (num) | Per flacon | Price | Buy |
| 2 | $21.93 | $43.86 (0%) | 🛒 Add to cart |
| 3 | $20.93 | $65.79 $62.78 (5%) | 🛒 Add to cart |
| 4 | $20.43 | $87.72 $81.70 (7%) | 🛒 Add to cart |
| 5 | $20.12 | $109.65 $100.62 (8%) | 🛒 Add to cart |
| 6 | $19.92 | $131.58 $119.54 (9%) | 🛒 Add to cart |
| 7 | $19.66 | $153.51 $137.60 (10%) | 🛒 Add to cart |
| 8 | $19.13 | $175.44 $153.08 (13%) | 🛒 Add to cart |
| 9 | $18.92 | $197.37 $170.28 (14%) | 🛒 Add to cart |
| 10 | $18.66
Best per flacon | $219.30 $186.62 (15%) | 🛒 Add to cart |
Synonyms | |||
Rogaine 2 (minoxidil topical solution 2%) is an FDA-approved over-the-counter medication designed to treat androgenetic alopecia, commonly known as pattern hair loss. Its active ingredient, minoxidil, works by prolonging the anagen (growth) phase of the hair follicle, increasing follicular size, and stimulating blood flow to the scalp. This non-prescription formulation is specifically indicated for the management of gradual hair thinning on the vertex (crown) of the scalp in both men and women. With consistent application as directed, it has demonstrated efficacy in slowing hair loss progression and promoting the regrowth of terminal hairs in responsive individuals.
Features
- Contains 2% minoxidil as the active pharmaceutical ingredient
- Available in an alcohol-based topical solution vehicle for optimal percutaneous absorption
- Delivered via metered-dose applicator for precise 1 mL dosage administration
- Formulated with propylene glycol to enhance minoxidil solubility and skin penetration
- Preservative-free formulation minimizes potential for cutaneous irritation
- Packaging includes graduated dropper for accurate measurement during application
Benefits
- Clinically demonstrated to stimulate hair regrowth in individuals with androgenetic alopecia
- Extends the duration of the anagen (growth) phase of the hair follicle cycle
- Increases follicular size and diameter of regrowing hairs
- Enhances microcirculation to the scalp through vasodilation of cutaneous blood vessels
- Prevents further miniaturization of hair follicles affected by pattern baldness
- Non-systemic action with primarily local pharmacological effects
Common use
Rogaine 2 is primarily indicated for the treatment of androgenetic alopecia (male and female pattern baldness) affecting the vertex (crown) of the scalp. It is most effective in individuals with recent onset of hair loss (less than 5 years duration) and smaller areas of alopecia (less than 10 cm in diameter). The product shows optimal results in patients under 40 years of age who have noticeable but not complete hair loss at the vertex. Clinical studies demonstrate response rates of approximately 40% for moderate hair growth and 20% for dense hair growth after 4 months of twice-daily application. Maintenance of results requires continued use, as discontinuation typically leads to reversal of benefits within 3-4 months.
Dosage and direction
Apply 1 mL of solution twice daily directly to the scalp in the hair loss area using the provided applicator. The total daily dose should not exceed 2 mL. Part hair to expose affected areas and apply directly to dry scalp. Gently massage into affected areas using fingertips. Wash hands thoroughly after application. Allow solution to dry completely before applying other hair care products or going to bed. Do not apply to other parts of the body. For optimal results, maintain consistent twice-daily application schedule. Clinical response typically becomes noticeable after 4 months of continuous use, though some individuals may require up to 12 months for maximal response.
Precautions
Do not use on irritated or sunburned scalp. Avoid contact with eyes, mucous membranes, and sensitive areas. Discontinue use if excessive scalp irritation develops. Patients with cardiovascular disease should consult physician before use due to potential systemic absorption. Monitor for signs of hypotension, tachycardia, or fluid retention. Not recommended for use with other topical scalp medications unless directed by physician. May cause temporary initial shedding of hairs during first 2-8 weeks of treatment as dormant follicles enter growth phase. This shedding typically subsides and is followed by regrowth. Store at room temperature away from heat and open flame.
Contraindications
Hypersensitivity to minoxidil, propylene glycol, or ethanol. History of pheochromocytoma. Patients with unexplained scalp lesions or inflammatory scalp conditions. Concomitant use with guanethidine or other potent vasodilators. Patients with history of orthostatic hypotension. Not for use in children under 18 years. Avoid in patients with history of heart failure, angina pectoris, or recent myocardial infarction. Contraindicated in patients with renal impairment or hepatic dysfunction.
Possible side effects
Most common: scalp itching, flaking, dryness, and erythema (occurring in approximately 7% of users). Dermatitis and contact allergic reactions in sensitive individuals. Temporary hypertrichosis (increased hair growth) on adjacent facial areas due to inadvertent transfer. Less frequently: headache, dizziness, lightheadedness. Rare systemic effects including tachycardia, palpitations, and fluid retention (occurring in <1% of users with proper application). Changes in hair texture or color have been reported anecdotally. Most local side effects diminish with continued use as the scalp adapts to treatment.
Drug interaction
Potential interaction with antihypertensive medications, particularly vasodilators and alpha-adrenergic blockers. Enhanced hypotensive effects when used concomitantly with diuretics or other blood pressure medications. Caution with topical corticosteroids or retinoids which may increase systemic absorption. Possible interaction with sympathomimetic drugs. No known interactions with oral contraceptives or hormone replacement therapy. Patients taking guanethidine should avoid use due to potential for severe orthostatic hypotension.
Missed dose
If a dose is missed, apply as soon as remembered unless it is nearly time for the next scheduled application. Do not double the dose to make up for a missed application. Maintain regular twice-daily schedule without excessive compensation. Consistency in application is more important than exact timing. If multiple doses are missed, resume regular dosing schedule without loading doses. Temporary interruption of treatment for up to 2 weeks typically does not significantly impact long-term efficacy, though optimal results require consistent use.
Overdose
Topical overdose may occur with application of excessive amounts or more frequent than recommended dosing. Symptoms may include hypotension, tachycardia, dizziness, syncope, and fluid retention. Systemic effects are more likely if applied to large areas or broken skin. In case of suspected overdose, discontinue use immediately and seek medical attention. Treatment is supportive and symptomatic. Monitor vital signs and electrolyte balance if significant systemic absorption is suspected. Hemodialysis is not effective for minoxidil removal due to high protein binding.
Storage
Store at controlled room temperature (20-25°C or 68-77°F). Keep container tightly closed when not in use. Protect from light and excessive heat. Do not freeze. Keep away from open flames as solution is flammable until completely dry. Discard 4 months after opening due to potential degradation of active ingredient. Keep out of reach of children and pets. Do not transfer to unmarked containers. Proper disposal of unused medication through medication take-back programs.
Disclaimer
This product is for external use only. Not for ophthalmic, oral, or intravaginal use. Individual results may vary. Not all users will experience hair regrowth. This product is not effective for receding frontal hairline or complete baldness. Discontinue use and consult physician if no improvement is seen after 4 months of treatment. Not intended for use by individuals with no family history of hair loss. Women should consult physician before use if pregnant, planning pregnancy, or breastfeeding. Keep out of reach of children. In case of accidental ingestion, seek immediate medical attention.
Reviews
Clinical studies demonstrate patient satisfaction rates of 60-70% among compliant users. Users report noticeable improvement in hair density and thickness after consistent 4-6 month use. Many patients note reduced hair shedding within first 2 months of treatment. Dermatologist surveys indicate 85% would recommend to appropriate candidates. Common positive feedback includes ease of use, non-greasy formulation, and visible results in crown area. Criticism primarily focuses on required long-term commitment, initial shedding phase, and limited efficacy for frontal hairline. Overall satisfaction correlates strongly with adherence to twice-daily application regimen and realistic expectations regarding degree of regrowth.